MFDS — authorised 20 August 1996
- Marketing authorisation holder: BOEHRINGER INGELHEIM
- Status: likely_approved
MFDS authorised Verluma on 20 August 1996
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MFDS authorised it on 20 August 1996.
BOEHRINGER INGELHEIM holds the South Korean marketing authorisation.